OCIAD2 antibody
Principal name
OCIAD2 antibody
Alternative names for OCIAD2 antibody
OCIA domain-containing protein 2, Ovarian carcinoma immunoreactive antigen-like protein
Ncbi ID
NP_001014446, NP_001014446.1, NM_152398, NP_081226.1, NM_026950, NM_001014446
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of OCIAD2 antibody
- Kit Component:
- - KN311430G1, Ociad2 gRNA vector 1 in pCas-Guide vector
- KN311430G2, Ociad2 gRNA vector 2 in pCas-Guide vector
- KN311430D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Ishiyama,T., et al. (2007) Cancer Sci. 98 (1), 50-57.
Oh,J.H., et al. (2005) Mamm. Genome 16 (12), 942-954.
Human 293T; WB Suggested Anti-OCIAD2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: 293T cell lysate; OCIAD2 antibody - middle region (ARP52941_P050) in Human 293T cells using Western Blot
Human Kidney: Formalin-Fixed, Paraffin-Embedded (FFPE)
Western blot analysis of OCIAD2 in A549 cell lysate with OCIAD2 antibody at (A) 0.5 and (B) 1 µg/ml.
Human Kidney: Formalin-Fixed, Paraffin-Embedded (FFPE)
Western blot analysis of OCIAD2 in SK-N-SH cell lysate with OCIAD2 antibody at (A) 0.5 and (B) 1 µg/ml.
Western blot analysis of OCIAD2 in A549 cell lysate with OCIAD2 antibody at (A) 0.5 and (B) 1 ug/mL.
Immunofluorescence of OCIAD2 in A549 cells with OCIAD2 antibody at 5 ug/mL.
Western blot analysis of OCIAD2 in SK-N-SH cell lysate with OCIAD2 antibody at (A) 0.5 and (B) 1 ug/mL.
Immunofluorescence of OCIAD2 in A549 cells with OCIAD2 antibody at 20 ug/mL.
WB Suggested Anti-OCIAD2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 62500; Positive Control: 293T cell lysate
Gel: 10%SDS-PAGE, Lysate: 40 ug, Lane: A172 cells, Primary antibody: (OCIAD2 Antibody) at dilution 1/250, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 10 minutes
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA306867 | OCIAD2 antibody |
||||||
| Rabbit Polyclonal OCIAD2 Antibody | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu | E, ICC/IF, WB |
0.1 mg /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA306868 | OCIAD2 antibody |
||||||
| Rabbit Polyclonal OCIAD2 Antibody | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu, Ms, Rt | E, ICC/IF, WB |
0.1 mg /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA350249 | OCIAD2 antibody |
||||||
| Rabbit Polyclonal Anti-OCIAD2 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP23912PU-N | OCIAD2 (C-term) antibody |
||||||
 |
Rabbit | Purified | Hu | E, ICC/IF, P, WB |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
| +1 additional image |
|||||||
| AP23913PU-N | OCIAD2 (N-term) antibody |
||||||
 |
Rabbit | Purified | Hu, Ms, Rt | E, ICC/IF, P, WB |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
| +1 additional image |
|||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY407566 | OCIAD2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR218411L2V | Lenti ORF particles, Ociad2 (GFP-tagged) - Mouse OCIA domain containing 2 (Ociad2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR218411L1V | Lenti ORF particles, Ociad2 (Myc-DDK-tagged) - Mouse OCIA domain containing 2 (Ociad2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
